IL13 and atopic eczema: Therefore, miR-143 may serve as a potential prophylactic and therapeutic target in the treatment of atopic dermatitis, acting as a suppressor of IL-13-induced dysregulation of skin barrier proteins in epidermal keratinocytes [58].